第 II 相反応: 硫酸化と α-アミノ酸との結合

Sulfation is a phase II biotransformation reaction that adds a polar sulfate group to drugs, enhancing water solubility and promoting excretion. Nonmicrosomal sulfotransferase enzymes catalyze this process using PAPS coenzyme activation. The sulfate group transfers to the drug substrate, generating a sulfated metabolite that can be readily eliminated from the body.

Drugs containing phenols, alcohols, aromatic amines, and amides undergo sulfation. Common examples include acetaminophen, minoxidil, and morphine. These drugs are metabolized through sulfation to form sulfoconjugates that are more water-soluble and easier to excrete than their parent compounds. Sulfation can occur independently or alongside other phase II pathways.

Sulfate conjugates are pharmacologically active and may cause tissue damage or carcinogenesis. Unlike some inactive metabolites, these sulfoconjugates retain biological activity, which can lead to adverse effects in tissues where they accumulate. This makes understanding sulfation metabolism clinically important for predicting drug safety and toxicity.

Alpha-amino acid conjugation links drugs to amino acids like glycine or glutamine, catalyzed by acyltransferases. Unlike sulfation, this reaction requires carboxylic acid activation and acylation steps. Drugs with aliphatic or aromatic carboxylic acids, such as valproic and salicylic acids, undergo this conjugation pathway.

Alpha-amino acid conjugation involves three steps: activating the carboxylic acid substrate, transferring the activated amino acid to the drug, and forming the conjugated metabolite. N-acyltransferase enzymes catalyze the acylation of the alpha-amino acid by the acyl CoA intermediate, producing a stable conjugate for excretion and elimination.

Sulfation can occur independently or alongside glucuronidation as competing phase II biotransformation pathways. Both reactions enhance drug water solubility and promote excretion, but sulfation uses PAPS coenzyme while glucuronidation uses UDP-glucuronic acid. The relative contribution of each pathway depends on drug structure and enzyme availability.

Phase II conjugation reactions like sulfation and amino acid conjugation are critical for predicting drug metabolism, efficacy, and safety. These reactions determine how quickly drugs are eliminated and whether metabolites retain biological activity. Mastering phase II reactions helps students understand drug interactions, individual variability in response, and adverse effects.